Yearly Archives: 2022

Orion Corporation and Abilita Therapeutics have entered into a research collaboration and option to license agreement to develop innovative antibody therapeutics in the areas...

The European Medicines Agency has approved Roche's Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use in the treatment of neovascular or ‘wet’...

Conduit Pharmaceuticals has entered into an agreement with Sarborg to leverage an advanced artificial intelligence (AI) and cybernetics platform to evaluate key deliverables across...